1 2 3

4 5 6

13 July 2016 EMA/321085/2016 Veterinary Medicines Division

Concept paper on guidance for the collection of data on antimicrobial consumption by species from national data collection systems

7

Agreed by European Surveillance of Veterinary Antimicrobial Consumption

4 July 2016

(ESVAC) species Expert Advisory Group Start of public consultation End of consultation (deadline for comments)

13 July 2016 30 September 2016

8 Comments should be provided using this template. The completed comments form should be sent to [email protected] 9

30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website www.ema.europa.eu/contact

An agency of the European Union

© European Medicines Agency, 2016. Reproduction is authorised provided the source is acknowledged.

10

1. Introduction

11

The European Surveillance of Veterinary Antimicrobial Consumption (ESVAC) activity work stream on

12

the collection of antimicrobial consumption data by animal species aims to foster the collection of

13

harmonised and standardised data in the European Union/European Economic Area (EU/EEA). One of

14

the objectives of this work stream is to provide guidance on the collection of antimicrobial consumption

15

data per animal species.

16

The guidance will outline the required data that an EU/EEA country should collect, and provide to

17

ESVAC, on the consumption of antimicrobials by species for those countries that are currently, or

18

might wish to start, collecting such data and would like to provide those data to ESVAC in the future.

19

The scope of the guidance will be the three major groups of food-producing animals (pigs, poultry and

20

cattle) but the guidance should be adaptable to other species as well.

21

The guidance will be developed in conjunction with the ESVAC species Expert Advisory Group (EAG).

22

The lessons learnt during the trial on the collection of antimicrobial consumption data from pig farms in

23

20141 will be taken into account. The guidance is intended to ensure the collection of harmonised and

24

standardised data at a supranational level and should therefore be applicable in all EU/EEA countries.

25

The collection of antimicrobial consumption data by animal species is one of the three work streams of

26

the ESVAC project; the outcome of the public consultation of the Draft ESVAC Vision and Strategy

27

2016-2020 (EMA/326299/2015) will be taken into account during the preparation of the guidance. This

28

guidance does not intend to prescribe if or how countries should set up systems for collection of data

29

on antimicrobial consumption in animals.

30

2. Problem statement

31

To enable development of the guidance the following needs to be established and defined:

32

1. antimicrobial consumption data per species (numerator), including minimum required variables to

33 34

be provided to ESVAC, data source, calculations, etc.; 2. animal population at risk of treatment with antimicrobials (denominator), including minimum

35

required variables to be provided to ESVAC, data source, calculations, etc.

36

3. Discussion (on the problem statement)

37

The consumption data (numerator) can be obtained from prescriptions/vet practice records, health

38

records/treatment log books, delivery notes and invoices, which could be collected from farm,

39

veterinarian or pharmacy records. The consumption data collected per observation can be the number

40

of packages per VMP (or VMP presentation), or the dosing regimen (including number of animals

41

treated) for a treatment with a VMP or medicated feed, or the total quantity of a VMP or medicated

42

feed. These data sources and types of consumption data may not deliver the same information;

43

therefore the potential impact on the numerator would need to be addressed.

44

Collection of the so-called 'raw' data should allow for the necessary quality control of the data by the

45

country and further analysis (e.g. calculation of total amount of the active substance used in a certain

46

animal species), but before providing the required data to ESVAC a country would have to aggregate

47

the observations for one species. The guidance needs to provide details on the level of aggregation of

48

those data. 1

See for full report: http://www.ema.europa.eu/docs/en_GB/document_library/Report/2016/05/WC500206990.pdf

Concept paper on guidance for the collection of data on antimicrobial consumption by species from national data collection systems EMA/321085/2016

Page 2/4

49

The animal population at risk for treatment with antimicrobials (i.e. the denominator), or a proxy

50

thereof, will be used to normalise the numerator and therefore it is important to assess which

51

denominator is the most suitable. The denominator should be based on population data that are

52

transparent and validated, preferably publicly available (e.g. Eurostat). The population data should

53

preferably be similar to those used to report ESVAC sales data2.

54

To allow for comparison of data collected from a representative sample to data collected from

55

practically the whole animal population for the species in question, a denominator for the farms

56

included in the sample has to be established as well. It needs to be explored during the development

57

of the guidance if data at farm level provide for similar/comparable categories of animals as those used

58

to derive the denominator at national level; if not, if a comparable denominator should be obtained.

59

In order to identify the required data that need to be collected and provided to ESVAC if providing data

60

by animal species, two major data collection models should be explored during the development of the

61

guidance; a 'census' model, involving the consumption during a year in practically all farms or the

62

whole animal population in an animal species/sector in a country, and a 'sample survey' model,

63

involving the consumption during a year in a representative sample of the animal population in an

64

animal species/sector in a country. An assessment of how these models can deliver the required data

65

should be attempted.

66

4. Recommendation

67

It is recommended to draft guidance on the collection of data on antimicrobial consumption per species

68

and on the animal population at risk for treatment with antimicrobials, with the following objective:

69

"To define the type and format of data to be provided to EMA/ESVAC from national data collection

70

systems collecting antimicrobial consumption data, in order for ESVAC to collate, analyse and report

71

harmonised and standardised data on antimicrobial consumption per species per country."

72

Guidance should, in the first instance, be created for three major groups of food-producing animals:

73

pigs, poultry and cattle, but might be adapted to other animal species at a later stage.

74

It is recommended that guidance refers to the collection of data per species on a national level for the

75

provision of those data to ESVAC; it will not cover reporting consumption per farm (e.g. for

76

benchmarking purposes), which remains for the countries' own consideration.

77

5. Proposed timetable

78

The concept paper will be released for consultation in July 2016. The deadline for comments will be

79

September 2016.

80

The draft guidance for public consultation is intended to be released by December 2016. The deadline

81

for comments will be March 2017. The expected date for adoption of the guidance is June 2017.

82

6. Resource requirements for preparation

83

The guidance will be prepared by the ESVAC species EAG in collaboration with the ESVAC team. One

84

physical meeting will take place in 2016 and Adobe Connect meetings will be organised as required.

2

See http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/document_listing/document_listing_000302.jsp&mid=WC 0b01ac0580153a00&jsenabled=true Concept paper on guidance for the collection of data on antimicrobial consumption by species from national data collection systems EMA/321085/2016

Page 3/4

85

7. Impact assessment (anticipated)

86

To clarify the requirements for collection of harmonised antimicrobial consumption data by animal

87

species, facilitating the setup of those systems.

88

8. Interested parties

89

Livestock producers, veterinarians, risk assessors, farmers' and veterinarians' associations, policy

90

makers, veterinary medicine authorities, etc.

91

9. References to literature, guidelines, etc.

92

Information on the ESVAC activity:

93

http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/document_listing/document_listing_

94

000302.jsp&mid=WC0b01ac0580153a00

Concept paper on guidance for the collection of data on antimicrobial consumption by species from national data collection systems EMA/321085/2016

Page 4/4

Draft concept paper on guidance for the collection of data on ...

Jul 13, 2016 - The lessons learnt during the trial on the collection of antimicrobial .... physical meeting will take place in 2016 and Adobe Connect meetings ...

126KB Sizes 0 Downloads 261 Views

Recommend Documents

Concept paper on the need for revision of the Note for Guidance on ...
Jul 21, 2016 - domains, e.g. cognition, are paramount across CNS disorders and warrant ... acceptance of the diagnostic and assessment tools available (7).

Concept paper on the need for revision of the Note for Guidance on ...
Jul 21, 2016 - 30 Churchill Place ○ Canary Wharf ○ London E14 5EU ○ United Kingdom. An agency of the European Union. Telephone +44 (0)20 3660 .... It is expected that the revised Guideline will be helpful in designing state of the art clinical

Concept paper on revision of Guidelines on the clinical investigation ...
Jul 21, 2016 - ... to regulatory decisions e.g. potency labelling and monitoring of patient .... the clinical trial concept taking into account the limits in availability ...

Concept paper on developing a guideline on Quality requirements of
Feb 16, 2017 - This concept paper addresses the need for development of a guideline on .... whether used alone or in combination, including the software ...

Concept paper on the need for revision of the guideline on the clinical ...
Aug 1, 2016 - Comments should be provided using this template. .... update, simplification and restructuring according to the new template. .... ICH Topic E 11.

Draft QRD guidance on the use of approved pictograms on the ...
Nov 25, 2016 - The safe and correct use of veterinary medicines depends on users being able to accurately read and. 30 understand the information on the ...

Concept paper on the use of adjuvanted veterinary vaccines
Dec 31, 2016 - An agency of the European Union ... European Medicines Agency, 2016. ... updating it to take account of more recent scientific developments ...

Concept paper on a revision of the guideline on the investigation of ...
Apr 7, 2017 - Send a question via our website www.ema.europa.eu/contact ... Specifying a cutoff (two-fold) for the inhibition constant 'Ki' shift to conclude ...

Concept paper on the need to revise Condition – Specific guidance ...
Apr 1, 2017 - guidance, Appendix 4 to the guideline on the evaluation ... 1. http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/ ...

Concept paper on revision of the Guideline on clinical development of ...
Jun 23, 2017 - It covers the design of clinical development. 16 ... consideration of size of the pre-licensure safety database by type of vaccine and its novelty;.

Detailed guidance on the electronic submission of information on ...
Apr 19, 2017 - basis in line with the requirements and business processes described in this ...... to support data analytics and business intelligence activities; ...

Detailed guidance on the electronic submission of information on ...
Apr 19, 2017 - marketing authorisation holders to the European Medicines Agency in accordance with Article .... Pharmacovigilance enquiry email (AP.7) .

Concept paper on a guideline on the evaluation of medicinal products ...
May 4, 2017 - influenza symptoms has been used as the primary efficacy endpoint in ... WHO Guidelines for Pharmacological Management of Pandemic ...

Concept paper for the revision of the guideline on veterinary medicinal ...
Dec 16, 2016 - Medicines Agency guideline to implement best practice with regard to 3Rs ... is not intended to increase the requirements for marketing authorisation ... e.g. FVE (Federation of Veterinarians of Europe), European College of.

Concept paper for the revision of the guideline on veterinary medicinal ...
Dec 8, 2016 - fluid therapy as stated in the guideline will remain: to correct dehydration and/or electrolyte. 43 imbalances and/or metabolic imbalances and, ...

Concept paper on the revision of the guideline for 4 veterinary ...
Dec 16, 2016 - Send a question via our website www.ema.europa.eu/contact ... oestrus, terminate unwanted gestation, prepare donors and recipients for the implantation of ... by appropriate data e.g. peer reviewed literature or own clinical.

Concept paper for the revision of GL on ... - European Medicines Agency
Sep 28, 2016 - that all potential issues are covered, the IWP is relying on industry's ... not covered by the existing guideline or listed in this concept paper and ...

Draft guideline on the clinical investigation of medicinal products for ...
Jun 23, 2016 - From a regulatory point of view, the following goals of a therapy can be .... 360 multidimensional scales are preferred over specific physical QoL ...

Draft guideline on equivalence studies for the demonstration of ...
Mar 23, 2017 - pharmacodynamic endpoints in the demonstration of therapeutic equivalence for locally applied, locally. 41 acting gastrointestinal products.

Draft Guidance for individual laboratories for transfer of quality control ...
Jul 21, 2016 - the application of the 3Rs) when considering the choice of methods to ... in the development, validation and dissemination of 3Rs approaches.

Guidance-Material-on-Comparison-of-Surveillance-Technologies ...
Page 2 of 47. Guidance Material on Surveillance Technology Comparison. Edition 1.0 September 2007 Page 2. TABLE OF CONTENTS. 1. Introduction.

External guidance on the implementation of the European Medicines ...
Apr 12, 2017 - Template cover letter text: “Redaction Proposal Document” package . ...... should be redacted, e.g. name, email, phone number, signature and ...

Presentation - Optimising the guidance on significant benefit ...
Apr 25, 2017 - Industry stakeholder platform on research and development support. Presented by Matthias Hofer on 25 ... authorisation application. Page 2. Orphan environment after 16 years of EU orphan legislation. Recent developments ...